StockUS listing USDVANYSEHealthcareDeep Value

DaVita HealthCare Partners Inc(DVA) Stock Analysis | Healthcare

USD --+0.00%
Reward59Moderate
Risk48Moderate
75%Data
USD —+0.00 (+0.00%) Previous close · NYSE
Market cap 10.13Bn
Reward Ratingⓘ59 Moderate reward assessment · 75% data coverage
Top 50% of stocksView factors
Risk Ratingⓘ48 Moderate risk assessment
Risk factors availableUnlock details

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

Educational tool only · More
Limited data coverage
We don't have enough public data on DVA to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available yet for this stock
The overview tab requires data we don't have for this stock yet. The price chart is the most reliable view we have — try the Chart tab.
Earnings Ex-dividend

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is DaVita HealthCare Partners Inc?

provides kidney dialysis services for patients suffering from chronic kidney failure in the United States.

AI Brief Pro

The brief on DaVita HealthCare Partners Inc

The story behind the price, the case for and against, and what could go wrong. Open a part to read it.

What is DaVita HealthCare Partners Inc?

provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. The company is listed on the NYSE in USA, operating in the Healthcare sector, with a market capitalisation of 10.13B, and a P/E ratio of 12.2x.

Financial Highlights

Investment Breakdown

Growth
Moderate growth momentum — positive trajectory without breakout acceleration.
Profitability
Adequate profitability with some margin variability in recent periods.
Risk
Risk profile appears balanced versus broad market conditions.
Valuation
Currently trading below intrinsic value estimates, suggesting upside potential.

OpenBook Logo Analysis

Reward: Moderate (59)
Company Information
SectorHealthcare
IndustryMedical Care Facilities
Beta0.858
Insider Activity
12M windowBearish
Shares soldShares bought
0-3months
1382,563 shares
$69.0M
0
3-6months
5267,792 shares
$54.3M
0
6-9months
61,309,560 shares
$200.1M
0
9-12months
11,658,480 shares
$199.9M
0